What is SION's cash ratio?

SION (SION) reported cash ratio of 6.6× in Q1 2026.

How has SION's cash ratio changed year-over-year?

SION's cash ratio decreased by 25.1% year-over-year, from 8.8× to 6.6×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

SION SION Cash ratio

Cash ratio at other companies

Vertex PharmaceuticalsVRTX

1.4×+0.2×

AbbVieABBV

0.2×+0.1×

Septerna, Inc.SEPN

0.9×-18.8×

BioCryst PharmaceuticalsBCRX

0.9×+0.1×

Denali Therapeutics Inc.DNLI

3.5×+2.9×

Neurocrine BiosciencesNBIX

0.3×-0.1×

Other financials

Income statement

See full

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

See full

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

See full

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

See full

Market cap$1.86B—

Returns & leverage

See full

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Where this comes from

Calculated from SION’s reported figures.

cash and equivalents/total current liabilities=6.6×

Based on the most recent quarter.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SION's cash ratio?: SION (SION) reported cash ratio of 6.6× in Q1 2026.
How has SION's cash ratio changed year-over-year?: SION's cash ratio decreased by 25.1% year-over-year, from 8.8× to 6.6×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.